Featured Founder: July 2022

Cabinet Health

Executive Summary:

• Cabinet Health sells over the counter (OTC) pharmaceutical products throughout the U.S. in categories like allergy relief and pain relief.

• Why we like Cabinet Health:

  • Cabinet Health has had over $10 million of sales for the past two years and we feel they have begun to find their “product-market fit”.

  • Our research has confirmed that “store-brand” (private-label) OTC pharmaceutical products are the most commonly purchased in the US and we see room for Cabinet Health to disrupt the market and uproot products like “store-brand” ibuprofen or allergy relief.

  • We believe this highly competent team of New Majority founders have the right experience and team of advisors to continue to scale the business as they expand sales. For a full description of their growth strategy read our full investment analysis below

  • This business has recently raised venture capital backing and so we feel confident that this mitigates financial risk (defined in-depth below) for investors who choose to invest in this round of equity crowdfunding

• Risk Summary:

  • The business is not profitable today because it has expenses which exceed its revenues. The main expenses are in logistics, sales, and marketing. Cabinet Health will need to manage the costs of its fulfillment centers and its third-party logistics if it wants to become profitable in the years ahead.

  • Cabinet Health has direct competition from companies like Genexa that sell to the same core audience.